White matter lesion progression: A surrogate endpoint for trials in cerebral small-vessel disease

Neurology

Volumn 63, Issue 1, 2004, Pages 139-144

  Schmidt, R ^a   Scheltens, Ph ^b   Erkinjuntti, T ^c   Pantoni, L ^d   Markus, H S ^e   Wallin, A ^f   Barkhof, F ^b   Fazekas, F ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF FLORENCE   (Italy)

^e ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CEREBRAL SMALL VESSEL DISEASE; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; COMMUNITY CARE; CONTROLLED STUDY; DEMENTIA; DISEASE COURSE; DISEASE MARKER; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MICROANGIOPATHY; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PRIORITY JOURNAL; WHITE MATTER; WHITE MATTER LESION;

EID: 3242668742     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000132635.75819.E5     Document Type: Article

References (49)

1. Bamford J, Sandercock P, Jones L, Warlow C. The natural history of lacunar infarction: the Oxfordshire Community Stroke Project. Stroke 1987;18:545-551.
2. Labovitz D, Sacco R. Intracerebral hemorrhage: update. Curr Opin Neurol 2001;14:103-108.
3. Offenbacher H, Fazekas F, Schmidt R, Koch M, Fazekas G, Kapeller P. MR of cerebral abnormalities concomitant with primary intracerebral hematomas. AJNR Am J Neuroradiol 1996;17:573-578.
4. Steifler JY, Eliasziw M, Benavente OR, et al. Development and progression of leukoaraiosis in patients with brain ischemia and carotid artery disease. Stroke 2003;34:1913-1916.
5. Vermeer SE, Hollander M, vanDijk EJ, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and white matter lesions increase stroke in the general population: the Rotterdam Scan Study. Stroke 2003;34:1126-1129.
6. Román G, Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC. Subcortical ischaemic vascular dementia. Lancet Neurol 2002;1:426-436.
7. Briley DP, Wasay M, Sergent S, Thomas S. Cerebral white matter changes (leukoaraiosis), stroke, and gait disturbance. J Am Geriatr Soc 1997;45:1434-1438,
8. van Gijn J. White matters: small vessels and slow thinking in old age. Lancet 2000;365:612-613.
9. Boone KB, Miller BL, Lesser IM, et al. Neuropsychological correlates of white matter lesions in healthy elderly subjects. A threshold effect. Arch Neurol 1992;49:549-554.
10. Carmelli D, DeCarli C, Swan G, et al. Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. Stroke 1998;29:1177-1181.
11. Hassan A, Hunt B, O'Sullivan M, et al. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaralosis. Brain 2003;126:1-8.
12. Schmidt R, Hayn M, Fazekas F, Kapeller P, Esterbauer H. Magnetic resonance imaging white matter hyperintensities in clinically normal elderly individuals. Correlations with plasma concentration of naturally occurring antioxidants. Stroke 1996;27:2043-2047.
13. Chabriat H, Levy C, Taillia H, et al. Patterns of MRI lesions in CADASIL. Neurology 1998;51:452-457.
14. Stock KW, Wetzl S, Kirsch E, Bongratz G, Steinbrich W, Radue EW. Anatomic evaluation of the circle of Willis: MR angiography versus intraarterial digital substraction angiography. AJNR Am J Neuroradiol 1996;17:1495-1499.
15. Blatter DD, Parker DL, Robison RO. Cerebral MR angiography with multiple overlapping thin slab acquisition. Part I. Quantitative analysis of vessel visibility Radiology 1991;179:805-811.
16. Hachinski V, Potter P, Merskey H. Leuko-araiosis. Arch Neurol 1987;44:21-23.
17. Pantoni L, Garcia J. The significance of cerebral white matter abnormalities 100 years after Binswanger's report: a review. Stroke 1995;26:1293-1301.
18. Fazekas F, Schmidt R, Kleinert R, Kapeller P, Roob G, Flooh E. The spectrum of age-associated brain abnormalities: their measurement and histopathological correlates J Neural Transm 1998;53(suppl):S31-S39.
19. Fazekas F, Kleinert R, Offenbacher H, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993;43:1683-1689.
20. Wahlund LO, Barkhof F, Fazekas F, et al. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001;32:1318-1322.
21. Sze G, De Armond SJ, Brant-Zawadzki M, Davis RL, Norman D, Newton TH. Foci of MRI signal (pseudo lesions) anterior to the frontal horns: histological correlations of a normal finding. AJR Am J Roentgenol 1986;147:331-337.
22. Englund E. Neuropathology of white matter lesions in vascular cognitive impairment. Cerebrovasc Dis 2002;13(suppl 2):11-15.
23. Fazekas F, Kleinert R, Roob G, et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol 1999;20:637-642.
24. Longstreth WT, Manolio TA, Arnold A, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996;27:1274-1282.
25. Breteler MM, van Swieten JC, Bots ML, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 1994;44:1246-1252.
26. Dichgans M, Filippi M, Bruning R, et al. Quantitative MRI in CADASIL: correlation with disability and cognitive performance. Neurology 1999;52:1361-1367.
27. Pantoni L, Lammie A. Cerebral small vessel disease: pathological and pathophysiological aspects in relation to vascular cognitive impairment. In: Erkinjuntfi T, Gauthier S, eds. Vascular cognitive impairment. London, UK: Martin Dunitz, 2002:115-133.
28. Baker AB, Iannone A. Cerebrovascular disease: III. The intracerebral arterioles. Neurology 1959;9:441-446.
29. Tomonaga M, Yamanouchi H, Toghi H, Kameyama MS. Clinicopathologic study of progressive subcortical vascular encephalopathy (Binswanger type) in the elderly. J Am Geriatr Soc 1982;30:524-529.
30. van Swieten JC, van den Hout JH, van Ketel BA, Hijdra A, Wokke JH, van Gijn J. Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces. Brain 1991;114:761-774.
31. Erkinjuntti T, Benavente O, Eliasziw M, et al. Diffuse vacuolization (spongiosis) and arteriolosclerosis in the frontal white matter occurs in vascular dementia. Arch Neurol 1996;53:325-332.
32. Wahlund L, Almkvist O, Basin H, Julin P. MRI in successful ageing, a 5-year follow-up study from eighth to ninth decade of life. Magn Res Imag 1996;14:601-608.
33. Veldink J, Scheltens P, Jonker C, Launer LJ. Progression of cerebral white matter hyperintensities on MRI is related to diastolic blood pressure. Neurology 1998;51:319-320.
34. Schmidt R, Fazekas F, Kapeller P, Schmidt H, Hartung H-P. MRI white matter hyperintensities: three-year follow-up of the Austrian Stroke Prevention Study. Neurology 1999;53:132-139.
35. Whitman G, Tang T, Lin MA, Baloh RW. A prospective study of cerebral white matter abnormalities in older people with gait dysfunction. Neurology 2001;57:990-994.
36. Schmidt R, Enzinger C, Ropele S, Schmidt H, Fazekas F. Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study. Lancet 2003;361:2046-2048.
37. Miller D, Grossman RI, Reingold SC, McFarland HF. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 1998;121:3-24.
38. Filippi M, Horsfield MA, Ader HJ, et al. Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis. Ann Neurol 1998;43:499-506.
39. Barkhof F, Filippi M, Miller DH, Tofts P, Kappos L, Thompson AJ. Strategies for optimizing MRI techniques aimed at monitoring disease activity in multiple sclerosis treatment trials. J Neurol 1997;244:76-84.
40. Scheltens P, Kittner B. Preliminary results from an MRI/CT-based database for vascular dementia and Alzheimer's disease. Ann NY Acad Sci 2000;903:542-546.
41. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
42. Molyneux P, Miller DH, Filippi M, et al. The use of magnetic resonance imaging in multiple sclerosis treatment trials: power calculations for annual lesion load measurement. J Neurol 2000;247:34-40.
43. McFarland HF, Barkhof F, Antel J, Miller DH. The role of MRI as a surrogate outcome measure in multiple sclerosis. Mult Scler 2002;8:40-51.
44. Pentice R. Surrogate markers in clinical trials: definition and operational criteria. Stat Med 1989;8:431-440.
45. Pantoni L, Leys D, Fazekas F, et al. Role of white matter lesions in cognitive impairment of vascular origin. Alzheimer Dis 1999;13(suppl 3):S49-S54.
46. Fazekas F, Ropele S, Bammer R, Kapeller P, Stollberger R, Schmidt R. Novel imaging technologies in the assessment of cerebral ageing and vascular dementia. J Neural Transm [Suppl] 2000;59:45-52.
47. Sullivan MO, Summers PE, Jones DK, Jarosz JM, William SCR, Markus HS. Normal appearing white matter in ischemic leukoaraiosis: a diffusion tensor MRI study. Neurology 2001;57:2307-2310.
48. Helenius J, Soinne L, Salonen O, Kaste M, Tatlisumak T. Leukoaraiosis, ischemic stroke, and normal white matter on diffusion-weighted MRI. Stroke 2002;33:45-50.
49. O'Sullivan M, Morris RG, Huckstep B, Jones DK, Williams SCR, Markus HS. Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis. J Neurol Neurosurg Psychiatry 2004;75:441-447.